T1	Action 31 40	diagnosis
T2	Action 45 54	isolation
T3	Action 58 68	infections
T4	Concept 78 86	COVID-19
T5	Concept 25 30	rapid
R1	has-property Arg1:T1 Arg2:T5	
R2	has-property Arg1:T2 Arg2:T5	
R3	target Arg1:T1 Arg2:T3	
R4	target Arg1:T2 Arg2:T3	
R5	in-context Arg1:T3 Arg2:T4	
T6	Action 108 115	control
A1	Negated T6
T7	Concept 95 100	alone
R6	has-property Arg1:T6 Arg2:T7	
T8	Action 116 125	outbreaks
T9	Concept 129 139	SARS-CoV-2
R7	subject Arg1:T8 Arg2:T9	
T10	Action 166 173	tracing
T11	Action 178 187	isolation
T12	Concept 198 203	cases
T13	Concept 191 197	traced
R8	has-property Arg1:T12 Arg2:T13	
T14	Concept 223 233	successful
R9	subject Arg1:T6 Arg2:T1	
R10	subject Arg1:T6 Arg2:T2	
R11	target Arg1:T6 Arg2:T8	
T15	Action 108 115	control
R12	target Arg1:T15 Arg2:T8	
R13	subject Arg1:T15 Arg2:T2	
R14	subject Arg1:T15 Arg2:T1	
R15	subject Arg1:T15 Arg2:T10	
R16	subject Arg1:T15 Arg2:T11	
R17	target Arg1:T11 Arg2:T12	
R18	has-property Arg1:T15 Arg2:T14	
T16	Concept 255 263	symptoms
T17	Concept 246 254	systemic
T18	Concept 239 245	common
R19	has-property Arg1:T16 Arg2:T17	
R20	is-a Arg1:T16 Arg2:T18	
T19	Concept 267 275	COVID-19
R21	in-context Arg1:T16 Arg2:T19	
T20	Concept 285 290	fever
T21	Concept 292 299	fatigue
T22	Concept 301 307	sputum
T23	Concept 312 319	myalgia
R22	is-a Arg1:T20 Arg2:T16	
R23	is-a Arg1:T21 Arg2:T16	
R24	is-a Arg1:T22 Arg2:T16	
R25	is-a Arg1:T23 Arg2:T16	
T24	Concept 331 340	prominent
T25	Concept 348 356	patients
T26	Concept 366 372	before
T27	Action 357 365	admitted
T28	Concept 373 383	January 23
R26	target Arg1:T27 Arg2:T25	
R27	in-time Arg1:T27 Arg2:T26	
R28	in-time Arg1:T26 Arg2:T28	
R29	has-property Arg1:T23 Arg2:T24	
R30	has-property Arg1:T22 Arg2:T24	
R31	has-property Arg1:T21 Arg2:T24	
R32	has-property Arg1:T20 Arg2:T24	
R33	in-context Arg1:T25 Arg2:T19	
R34	in-context Arg1:T24 Arg2:T27	
T29	Action 426 434	admitted
T30	Concept 417 425	patients
T31	Concept 404 413	insidious
T32	Concept 435 440	later
R35	in-time Arg1:T29 Arg2:T32	
R36	in-time Arg1:T32 Arg2:T28	
R37	has-property Arg1:T23 Arg2:T31	
R38	has-property Arg1:T22 Arg2:T31	
R39	has-property Arg1:T21 Arg2:T31	
R40	has-property Arg1:T20 Arg2:T31	
R41	target Arg1:T29 Arg2:T30	
R42	in-context Arg1:T30 Arg2:T19	
R43	in-context Arg1:T31 Arg2:T29	
T33	Action 474 484	monitoring
T34	Concept 468 473	fetal
R44	target Arg1:T33 Arg2:T34	
T35	Concept 495 512	serial ultrasound
T36	Concept 517 522	women
T37	Concept 528 536	COVID-19
R45	is-a Arg1:T35 Arg2:T33	
R46	in-context Arg1:T35 Arg2:T36	
R47	in-context Arg1:T36 Arg2:T37	
T38	Action 655 670	immunodepletion
T39	Concept 676 696	refractory hypoxemia
R48	in-context Arg1:T38 Arg2:T39	
T40	Concept 712 721	high risk
T41	Concept 702 711	potential
T42	Concept 722 729	subtype
R49	has-property Arg1:T42 Arg2:T40	
R50	has-property Arg1:T42 Arg2:T41	
T43	Concept 733 743	COVID-2019
R51	in-context Arg1:T42 Arg2:T43	
T44	Concept 760 766	circle
T45	Concept 752 759	vicious
R52	has-property Arg1:T44 Arg2:T45	
T46	Concept 767 774	between
R53	in-context Arg1:T44 Arg2:T46	
T47	Concept 775 790	immune disorder
T48	Concept 795 808	gut dysbiosis
R54	in-context Arg1:T46 Arg2:T47	
R55	in-context Arg1:T46 Arg2:T48	
T49	Concept 818 827	high risk
T50	Concept 837 846	pneumonia
T51	Concept 831 836	fatal
R56	has-property Arg1:T50 Arg2:T51	
R57	in-context Arg1:T49 Arg2:T50	
R58	is-a Arg1:T44 Arg2:T49	
R59	is-a Arg1:T38 Arg2:T42	
T52	Concept 847 858	Lymphopenia
T53	Concept 865 874	effective
T54	Action 888 897	indicator
T55	Concept 879 887	reliable
R60	has-property Arg1:T54 Arg2:T55	
R61	has-property Arg1:T54 Arg2:T53	
T56	Concept 901 909	severity
T57	Concept 914 929	hospitalization
R62	target Arg1:T54 Arg2:T56	
R63	target Arg1:T54 Arg2:T57	
T58	Concept 942 950	patients
T59	Concept 933 941	COVID-19
R64	in-context Arg1:T54 Arg2:T58	
R65	is-a Arg1:T52 Arg2:T54	
R66	in-context Arg1:T58 Arg2:T59	
